AVENUE THERAPEUTICS, INC. Stockholders' Equity Attributable to Noncontrolling Interest
AVENUE THERAPEUTICS, INC. (ATXI) had Stockholders' Equity Attributable to Noncontrolling Interest of $0 as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2026-03-30
- 2025-12-31: Stockholders' Equity Attributable to Noncontrolling Interest $0.00.
- 2025-09-30: Stockholders' Equity Attributable to Noncontrolling Interest -$1.25M.
- 2025-06-30: Stockholders' Equity Attributable to Noncontrolling Interest -$1.23M.
- 2025-03-31: Stockholders' Equity Attributable to Noncontrolling Interest -$1.18M.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-30 |
| 2025-09-30 | -$1.25M 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$1.23M 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$1.18M 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$941.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | -$958.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$937.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | -$938.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$928.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$872.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$810.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | -$705.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$639.00K 10-K · filed 2024-03-18 |